CLBK

Columbia is a $11.0B-asset federal savings institution whose earnings have whipsawed: $92.0M (FY21) → $86.2M (FY22) → $36.1M (FY23) → a $11.7M loss (FY24) → $51.8M (FY25). The headline '+544% net income' is real but flatters a recovery off a depressed base — FY24's loss was driven by the December 2024 balance-sheet repositioning (sold $352.3M of securities at a ~$37.9M pre-tax loss to prepay $170.0M of higher-cost borrowings and fund loan growth). That repositioning is described as 'immediately accretive to net interest income,' which is the legitimate bull case for forward earnings. But the franchise is still low-return: ROE is just 4.5%, and at $21.03 the stock trades ~1.9x its ~$11.15 book value (equity $1.16B / 104M shares) and 41.2x diluted EPS of $0.51 — rich multiples for a thrift earning well below its own historical peak.

The dominant variable isn't the run-rate at all — it's the pending second-step conversion from mutual holding company to full stock form, bundled with the acquisition of Northfield Bancorp, targeted for Q3 2026. Management states it is 'not aware of any circumstances likely to cause the acquisition not to occur,' yet flags that regulatory, stockholder and member approvals remain unsatisfied 'one or more of which we may not obtain.' The filing is explicit that the new-share issuance to Northfield holders 'may result in… a stock price decrease' and that integration could be 'more difficult, costly or time consuming than expected.' This is a binary, event-driven setup: the elevated price-to-book likely already embeds conversion optimism, so the asymmetry is unattractive — upside is capped by a known catalyst while downside opens if approvals slip or terms disappoint.